The role of the carnitine pool has expanded from FAO to more biological processes [3, 4]
These unique structural features, particularly the way it engages with the receptors, are proposed to contribute to its potent and long-acting clinical efficacy as a dual agonist for weight management
Presence of a Functional Receptor for GLP-1 in Osteoblastic Cells, Independent of the cAMP-Linked GLP-1 Receptor
SCNC of the larynx are uncommon but well-recognized neoplasms (32, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)
Understanding this distinction is relevant for individuals discussing options with their healthcare providers